Search Results 801-810 of 14750 for anti-TNF drugs

  1. Pentetate Zinc Trisodium (Intravenous Route, Inhalation Route) Side Effects - Mayo Clinic

    Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or ...

  2. Pentazocine And Naloxone (Oral Route) Description and Brand Names - Mayo Clinic

    Pentazocine and naloxone combination is used to relieve pain severe enough to require opioid treatment and when other pain medicines did not work well enough or ...

  3. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    ... drugs are safe for people to take. We also want ... the total duration of the drug treatment and the drug washout period ... - Hepatitis B core antibody (anti-HBc) ...

  4. Tryptophan (Oral Route) Before Using - Mayo Clinic

    There is no specific information comparing use of L-tryptophan in the elderly with use in other age groups. Drug Interactions. Although certain medicines should ...

  5. Prophylactic Benzodiazepine versus Reinstitution of Maintenance Antiseizure Drugs following Ictal SPECT - Mayo Clinic

    Prophylactic Benzodiazepine versus Reinstitution of Maintenance Antiseizure Drugs following Ictal SPECT · Overview · Participation eligibility · Participating Mayo ...

  6. Doxorubicin (Intravenous Route) Description and Brand Names - Mayo Clinic

    Doxorubicin injection is used together with other medicines to treat cancer of the blood, lymph system, bladder, breast, stomach, lungs, ovaries, thyroid, ...

  7. Reslizumab (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  8. Namilumab in Subjects with Chronic Pulmonary Sarcoidosis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Use of biologic — approved or investigational agents (e.g., anti-TNFα, anti ...

  9. Talquetamab-Tgvs (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Talquetamab-Tgvs ... These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal ...

  10. Ubrogepant (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...